[ad_1]
Surface oncology Q3 2023 Earnings Estimates Lowered by Wedbush Clayton County Register
[ad_2]
Source link
Gastrointestinal (GI) Cancers- Side Effects
Gastrointestinal (GI) cancers, which include cancers of the esophagus, stomach, liver, pancreas, and colorectal region, can cause a range of side effects due to the location and treatment of the tumors. The side effects can vary depending on the specific type of GI cancer, the stage of the disease, the treatment received (surgery, chemotherapy, radiation, immunotherapy, etc.), and individual factors. Here are some common side effects associated with GI cancers:
Nausea and vomiting: These side effects can be caused by the cancer itself or as a result of chemotherapy, radiation therapy, or certain medications used in treatment.
Diarrhea or constipation: GI cancers can disrupt normal bowel function, leading to changes in bowel habits. Some cancer treatments may also cause diarrhea or constipation.
Abdominal pain: Tumors in the GI tract can cause localized or generalized abdominal pain. Treatment procedures like surgery or radiation may also lead to postoperative pain.
Fatigue: Cancer and its treatments can lead to fatigue and weakness, impacting a person’s overall energy levels.
Loss of appetite and weight loss: GI cancers can affect a person’s ability to eat and digest food properly, leading to a loss of appetite and unintended weight loss.
Difficulty swallowing (dysphagia): Esophageal and stomach cancers can make swallowing difficult, causing pain and discomfort.
Jaundice: Liver and pancreas cancers can obstruct the bile ducts, leading to jaundice, a yellowing of the skin and eyes.
Gastrointestinal bleeding: Tumors in the GI tract may cause bleeding, leading to symptoms like black, tarry stools (melena) or bright red blood in the stool.
Changes in taste and smell: Some cancer treatments can alter a person’s sense of taste and smell, making certain foods less appealing.
Emotional and psychological effects: Dealing with GI cancer and its treatment can lead to emotional distress, anxiety, and depression.
Weak immune system: Cancer and its treatments can weaken the immune system, making the person more susceptible to infections.
More information – https://oncologyandcancerresearch.blogspot.com/
International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco
For Inquiries: oncology@pencis.com
#shorts #shortsvideo #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference #CardioOnc #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney
CONNECT HERE:-
Facebook : https://www.facebook.com/Conference-101261931798599
twitter :https://twitter.com/Samirabellil
pinterest : https://in.pinterest.com/OncologyandCancerResearch/
Blog :https://oncologyandcancerresearch.blogspot.com/
tumblr :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin : https://www.linkedin.com/in/cathenna-malia-a20834219/
source
Cancer-killing pill that annihilates tumours hailed as ‘holy grail’ breakthrough
[ad_1]
oncology.pencis.com/” target=”_blank”>
oncology.pencis.com/” target=”_blank”>
oncology.pencis.com/” target=”_blank”>Scientists have developed a ‘holy grail’ molecule that kills all solid cancer tumours, leaving healthy cells unaffected.
oncology.pencis.com/” target=”_blank”>The team at the City of Hope, one of the largest cancer Research and treatment organisations in the US, made the breakthrough against the proliferating cell nuclear antigen (PCNA) protein.
oncology.pencis.com/” target=”_blank”>In a mutated form PCNA is critical in DNA replication and repair of all expanding tumours, but a molecule developed by the team, AOH1996, targets and kills the mutated PCNA.
oncology.pencis.com/” target=”_blank”>Previously PCNA was thought too challenging to be a target for therapy, but preclinical Research shows AOH1996 seems to annihilate all solid tumours – without effects on other body cells.
oncology.pencis.com/” target=”_blank”>‘Results have been promising,’ said Dr Malkas. ‘AOH1996 can suppress tumor growth as a monotherapy or combination treatment in cell and animal models without resulting in toxicity.
oncology.pencis.com/” target=”_blank”>‘The investigational chemotherapeutic is currently in a Phase 1 clinical trial in humans at City of Hope.’
oncology.pencis.com/” target=”_blank”>The researchers have tested AOH1996 in more than 70 cancer cell lines and several normal control cells. They found the molecule selectively kills cancer cells by disrupting the normal cell reproductive cycle.
oncology.pencis.com/” target=”_blank”>In their Research, the team has found AOH1996 prevented cells with damaged DNA from dividing and from making a copy of faulty DNA, causing cancer cell death – known as apoptosis – but it did not interrupt healthy stem cells.
oncology.pencis.com/” target=”_blank”>‘Conference-registration-gbp/”>Undruggable’, but City of Hope was able to develop an investigational medicine for a challenging protein target.
oncology.pencis.com/” target=”_blank”>‘We discovered that PCNA is one of the potential causes of increased nucleic acid replication errors in cancer cells.
oncology.pencis.com/” target=”_blank”>‘Now that we know the problem area and can inhibit it, we will dig deeper to understand the process to develop more personalised, targeted cancer medicines.’
oncology.pencis.com/” target=”_blank”>Experiments showed that the investigational pill made cancer cells more susceptible to chemical agents that cause DNA or chromosome damage, hinting that AOH1996 could become a useful tool in combination therapies and new chemotherapeutics.
oncology.pencis.com/” target=”_blank”>Professor Daniel Von Hoff, co-author, added: ‘City of Hope has world leaders in cancer Research. They also have the infrastructure to drive translational drug discovery from the laboratory into the clinic for patients in need.’
oncology.pencis.com/” target=”_blank”>The Phase 1 clinical trial began in October.
oncology.pencis.com/” target=”_blank”>As a next step, the researchers will look to better understand the mechanism of action to further improve the ongoing clinical trial in humans.
oncology.pencis.com/” target=”_blank”>The team is continuing to investigate the mechanisms that make this cancer-stopping pill work in animal models, while a Phase 1 clinical trial test is also ongoing in humans.
oncology.pencis.com/” target=”_blank”>However, it is not yet known if the drug will continue to be taken in pill form once fully developed and approved for use.
oncology.pencis.com/” target=”_blank”>The new therapy is the result of 20 years of Research and development – and is named after Anna Olivia Healey (AOH), a young girl born in 1996 who unfortunately was not able to beat cancer.
oncology.pencis.com/” target=”_blank”>‘Most targeted therapies focus on a single pathway, which enables wily cancer to mutate and eventually become resistant,’ said team leader Dr Linda Malkas, a professor in City of Hope’s department of molecular diagnostics and experimental therapeutics.
oncology.pencis.com/” target=”_blank”>‘PCNA is like a major airline terminal hub containing multiple plane gates.
oncology.pencis.com/” target=”_blank”>‘Data suggests PCNA is uniquely altered in cancer cells, and this fact allowed us to design a drug that targeted only the form of PCNA in cancer cells.
oncology.pencis.com/” target=”_blank”>‘Our cancer-killing pill is like a snowstorm that closes a key airline hub, shutting down all flights in and out only in planes carrying cancer cells.’
oncology.pencis.com/” target=”_blank”>The study, published in the journal Cell Chemical Biology, claims AOH1996 has been effective in preclinical Research treating cells derived from breast, prostate, brain, ovarian, cervical, skin and lung cancers.
#prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #Conference-registration-usd/”>Lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference #CardioOnc #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #Conference-registration-usd/”>Lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney
[ad_2]
cancer-killing-pill-that-annihilates.html”>Source link
Can The NHS Survive?
[ad_1]
Can the NHS survive? This is one thing that has been on my mind for many years, but particularly since covid. We can all argue about why we are in this position, but we are! It will be a close run thing, if we can bring our NHS back from where we are today. Personally I believe that it is political will, to destroy it. Otherwise why would there be such little concern for the service and it’s staff? Healthcare in the UK may be so problematic, that it is now too expensive for the public purse? Below I have laid out some of the issues to be urgently considered.
Introduction:
The National Health Service (NHS) has long been a symbol of pride for the United Kingdom, providing healthcare services to its citizens since its inception in 1948. However, in recent years, concerns about the sustainability and future of the NHS have emerged. In this blog post, we will delve into the challenges, and potential solutions facing the NHS. Analysing whether it will be able to survive and continue serving the needs of the UK population.
Rising Demand and Funding Pressures
The NHS faces the constant challenge of rising demand for healthcare services, due to various factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical treatments. This surge in demand, puts immense pressure on the NHS, exacerbating funding constraints, and stretching resources thin. To ensure the NHS’s survival, it is crucial to address these challenges, through long-term funding commitments, innovative financing models, and proactive health promotion strategies.
The aging population in the UK has led to a significant increase in the number of individuals requiring healthcare services. As people live longer, they tend to develop more complex conditions, leading to higher demand for specialized care. Additionally, the rising prevalence of chronic diseases further burdens the NHS as these require ongoing management.
Technological Advancements and Digital Transformation
Moreover, constant advancements in medical treatments and technologies, have expanded healthcare possibilities. But often come with a hefty price tag. New medications, equipment, and procedures contribute to rising healthcare costs. The NHS must balance, providing the latest treatments, whilst managing its finances effectively.
While technology presents opportunities, through digitization and automation, to streamline processes and improve patient care. Implementing these, requires substantial investment, robust cybersecurity, and comprehensive training for healthcare professionals. Efforts should ensure vulnerable populations are not left behind, during the NHS’s digital transformation.
Workforce Crisis and Staffing Shortages
The NHS has been grappling with a workforce crisis. With shortages of healthcare professionals partly due to increasing workloads, burnout, and limited funding for training and recruitment. Addressing these challenges by targeting recruitment, improving retention strategies, and investing in professional development is vital to secure the NHS’s survival.
The demanding nature of healthcare work, has led to increased burnout and high turnover rates, making it difficult to retain experienced staff. Moreover, limited funding for training and recruitment, exacerbates this problem. Investing in workforce programs, improving working conditions, and providing adequate support systems can contribute to a more resilient workforce.
Political Will and Public Support
The survival of the NHS, is linked to political will and public support. Policymakers must prioritize healthcare in their agendas, and allocate sufficient resources to ensure the NHS’s sustainability. Fostering public awareness and support can also drive necessary policy changes.
Maintaining public support requires transparent communication, about the complexities of funding and resources. By making healthcare a priority, policymakers can enact policies supporting the NHS’s long-term sustainability through strategic investments.
Potential Solutions for a Sustainable Future
To ensure the NHS’s survival, a long-term funding commitment is needed, to meet rising demand. Exploring financing models, like public-private partnerships can help bridge funding gaps. Investing in preventive care and public health initiatives can also alleviate the burden by reducing the need for costly interventions.
Embracing technology advancements and digitization, can enhance efficiency and effectiveness. Targeted recruitment, improved retention strategies, and professional development investment are essential to address the workforce crisis.
Conclusion
While the NHS faces numerous challenges, viable solutions of long-term funding, technology adoption, workforce strategies, and political support can pave the way for a sustainable future. We must recognize the NHS’s importance, and work towards its preservation, ensuring accessible, high-quality care for generations.
Our NHS has gone backwards in at least the last 10 years. Therefore, even if we can save it, we won’t again have a service we can be proud of, for possibly 20 years, if you include sorting out it’s decaying infrastructure too. The policy that we have seen, has not saved our country money, but cost it so much! Both financially, and the welfare of our people. We are now more reliant on big pharma than we were. Was that the plan all along? If you think that inequality is bad now, don’t even give any thought to private healthcare!
As always these are my personal thoughts and opinions based on my experiences. Please feel free to share your own below.
The post Can The NHS Survive? appeared first on Chris's cancer Community.
[ad_2]
Source link
Effects of Precision Medicine
Precision medicine has had a profound impact on cancer research and treatment.
Genetic Profiling: Precision medicine involves analyzing the genetic makeup of a patient’s tumor to identify specific mutations or alterations that drive cancer growth. This information helps oncologists select targeted therapies designed to address these specific genomic abnormalities.
Targeted Therapies: Targeted therapies are drugs that selectively attack cancer cells based on specific molecular characteristics. Precision medicine has led to the development of numerous targeted therapies, which often have fewer side effects compared to traditional chemotherapy because they spare healthy cells.
Companion Diagnostics: As precision medicine has advanced, so has the development of companion diagnostics. These are tests that identify patients who are most likely to respond positively to a particular targeted therapy, ensuring that treatment resources are used more effectively.
Treatment Resistance Management: Resistance to cancer treatments is a significant challenge. Precision medicine allows for the identification of resistance mechanisms, enabling healthcare providers to adapt treatment strategies and overcome resistance when it occurs.
Early Detection and Risk Assessment: Precision medicine has facilitated the identification of genetic markers associated with increased cancer risk. This enables early detection and risk assessment for individuals with a familial history of cancer, leading to timely interventions and improved outcomes.
Liquid Biopsies: Liquid biopsies are a non-invasive alternative to traditional tissue biopsies. These tests analyze circulating tumor DNA or other biomarkers in the blood to monitor treatment response, detect disease recurrence, and provide real-time insights into the tumor’s genetic profile.
Immunotherapy Advancements: Immunotherapy, which harnesses the body’s immune system to fight cancer, has seen significant advancements due to precision medicine. Identifying predictive biomarkers allows for better patient selection for immunotherapies, leading to improved responses.
Clinical Trial Design: Precision medicine has transformed the way clinical trials are designed and conducted. Trials can now be focused on specific patient populations with particular genetic profiles, making the development of new therapies more efficient.
Integration of Data and AI: The wealth of genomic and clinical data generated by precision medicine has led to the integration of artificial intelligence (AI) and machine learning in cancer research. AI helps analyze complex datasets and identify patterns that may lead to new therapeutic discoveries.
Challenges and Future Directions: Despite its successes, precision medicine in cancer still faces challenges, such as tumor heterogeneity, data-sharing, and cost considerations. Researchers continue to work on expanding precision medicine approaches to more cancer types and optimizing treatment strategies.
More information – https://oncologyandcancerresearch.blogspot.com/
International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco
For Inquiries: oncology@pencis.com
#shorts #shortsvideo #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney
CONNECT HERE:-
Facebook : https://www.facebook.com/Conference-101261931798599
twitter :https://twitter.com/Samirabellil
pinterest : https://in.pinterest.com/OncologyandCancerResearch/
Blog :https://oncologyandcancerresearch.blogspot.com/
tumblr :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin : https://www.linkedin.com/in/cathenna-malia-a20834219/
source
Using Technology to Find Cancers Early and Exercise Improves Sexual Health for People With Prostate Cancer: Research from the 2023 ASCO Breakthrough Meeting
[ad_1]
The 2023 American Society of Clinical oncology (ASCO) Breakthrough meeting will be held in person and online August 3 to 5 in Yokohama, Japan. This meeting shines a light on the cutting-edge advances that are transforming cancer care in Asia and beyond. Research highlighted at ASCO Breakthrough will explore how new technologies may intersect with clinical care today to improve patients’ lives and well-being.
You can learn more about research from this meeting by following the #ASCOBT23 hashtag on Twitter.
Below are summaries of 4 studies that will be presented at the meeting:
Stool DNA test accurately detects gastrointestinal cancers and identifies tumor location
Who does this study affect: People at risk for gastrointestinal cancers.
What did this study find: A study out of China found that a new, noninvasive multi-target stool DNA test was able to accurately detect gastrointestinal (GI) cancers and identify the location where the cancer started.
GI cancers are cancers that affect the body’s GI tract, which is the bodily system involved in swallowing and digesting food, absorbing nutrients, and removing waste from the body. These cancers include cancer.net/cancer-types/bile-duct-cancer-cholangiocarcinoma”>bile duct cancer, colorectal cancer, esophageal cancer, pancreatic cancer, and stomach cancer, among others. Overall, GI cancers make up one-fourth of cancer cases around the world, according to the World Health Organization.
While tests using either stool (feces) or Blood have been approved by the U.S. Food and Drug Administration for the early detection of colorectal cancer, there are currently no similar tests approved for the early detection of other GI cancers. Stool tests are noninvasive, and most people can do the test at home. In this study, researchers wanted to learn whether using a new stool DNA test could detect and locate more GI cancers early.
The study included 124 Chinese people who had been diagnosed with GI cancer but had not received treatment, as well as 92 people who did not have cancer but received GI cancer-related examinations every 3 years.
The study showed that the test was able to accurately detect GI cancers and identify the location where the cancer started. Overall, of the patients who had cancer, 79% tested positive for cancer with the test, and of the patients who did not have cancer, 96% tested negative for cancer. Of the 4 participants who did not have cancer but received a positive result from the test, 3 were diagnosed with advanced adenomas, which are benign tumors that can become cancerous, and 1 person was pregnant.
For each of the specific GI cancer types included in the study, the test positively identified 71% of colorectal cancer cases, 83% of stomach cancer cases, 75% of esophageal cancer cases, 81% of pancreatic cancer cases, and 91% of ampullary cancer cases. Ampullary cancer is cancer of the ampulla of Vater, which is where the pancreatic duct and bile duct meet and empty into the first part of the small intestine.
The researchers also evaluated how effective the test was in identifying the type of GI cancer, which is called sensitivity. Sensitivity is the percentage of people with cancer who were correctly identified by the test as having cancer. The sensitivity of the test was 88% for colorectal cancer, 91% for stomach cancer, 88% for esophageal cancer, 90% for pancreatic cancer, and 95% for ampullary cancer.
What does this mean for patients: This noninvasive stool DNA test could help detect different GI cancers early and accurately, including the location where the cancer started.
“Stool is a promising sample for GI cancer detection because it contains the host’s exfoliated cells and circulating-free DNA derived from GI cancer cells. Our study aims to develop a noninvasive, multi-target stool DNA methylation test for the early detection and localization of GI cancers.”
— lead study author Li-Yue Sun, MD
Guangdong Second Provincial General Hospital
Guangzhou, China
Exercise helps improve sexual health for people with prostate cancer
Who does this study affect: People with cancer.net/cancer-t%C3%BDpes/prostate-cancer“>prostate cancer.
What did this study find: Results from a randomized, controlled clinical trial from Australia found that patients who followed a supervised exercise program had improved sexual health. Prostate cancer and its treatment can lead to problems with sexual health, including erectile dysfunction and a loss of sexual desire. These sexual side effects may be temporary, but some can last for a long time. Side effects that change sexual health can affect a person mentally, emotionally, and physically.
In this study, the researchers wanted to see whether supervised resistance and aerobic exercise given in the clinic would improve sexual health. Aerobic exercise is also known as cardio, and it is the type of exercise that raises your heart rate. Resistance exercise is also called strength training. The researchers also wanted to explore whether adding a type of counseling called psychosexual therapy would help.
The study included 112 men with prostate cancer who had or were receiving cancer treatment and who had concerns about problems with sexual health. This study was done at exercise clinics that were connected to universities between 2014 and 2018. The participants were divided into 3 study groups. Group 1 included 39 people who received 6 months of supervised resistance and aerobic exercise in a group setting for 3 days per week. The 36 patients in Group 2 received the same exercise program plus psychosexual therapy. The 37 patients in Group 3 received usual care for prostate cancer, which does not include supervised exercise instruction.
The researchers evaluated whether the participants in Groups 1 and 2 were more satisfied with their sexual function than those in Group 3. To do this, participants were asked to complete a questionnaire called the International Index of Erectile Function (IIEF), which scores a person’s sexual ability and satisfaction with sexual activity. Those who participated in the supervised exercise program had a 5.1-point increase in their ability to have an erection of the penis compared with a 1.0-point increase in those who received usual care. Those who received supervised exercise also were more satisfied with sexual intercourse. Their satisfaction with sex increased by 2.2 points, compared with 0.2 points for those who received usual care. The psychosexual therapy, which was self-managed, did not add any improvements for the participants.
What does this mean for patients? Supervised resistance and aerobic exercise improved ability to have an erection and satisfaction with sexual intercourse for patients with prostate cancer.
“Nearly half of patients with prostate cancer report having unmet sexual health care needs, highlighting the lack of current health care services to adequately address the demand for management of sexual dysfunction after prostate cancer treatment. Our study shows that these patients can immediately benefit from supervised exercise interventions to improve their sexual health and that exercise should be considered as an integral part of treatment for prostate cancer.”
—lead study author Daniel Abido Galvao, PhD
Edith Cowan University
Perth, Australia
Return to top
Artificial intelligence can accurately identify cervical precancerous lesions during colposcopy
Who does this study affect: People at increased risk for cancer.net/cancer-types/cervical-cancer“>cervical cancer.
What did this study find: A study out of Japan found that a new artificial intelligence (AI)-based model can accurately identify cervical intraepithelial neoplasia (CIN) lesions from videos taken during colposcopy. CIN, which may also be called cervical dysplasia, is an abnormal growth of cells on the cervix, which is part of the female reproductive system. While some of these abnormal cells may go away without treatment, others may eventually become cervical cancer.
A colposcopy is a procedure used to find cancerous or abnormal cells in the cervix, vagina, or vulva. A colposcopy may be recommended for people who received abnormal results following a Pap test so the doctor can confirm and diagnose certain problems, including CIN. During a colposcopy, the doctor may also perform a biopsy, which is the removal of a small amount of tissue for examination under a microscope, to determine whether abnormal areas found during the colposcopy may be cancerous or precancerous.
Extensive colposcopy training is required to teach doctors how to accurately detect CIN and perform more precise biopsies of suspicious areas. In this study, researchers wanted to learn whether an AI-based model could be used to accurately identify precancerous lesions from colposcopy results and help guide where biopsies should be performed.
Researchers conducted an analysis using 8,341 videos recorded during colposcopies from 2013 to 2019. The videos included 7 early-stage cervical cancer cases, 203 CIN3 cases, 276 CIN2 cases, and 456 CIN1 cases. CIN1 lesions have the lowest risk of becoming cancer, while CIN3 lesions have the highest risk of becoming cancer.
Researchers then trained the AI-based lesion detection model by showing it videos of 60 cases of cervical cancer and CIN3. The AI-based model was then shown 150 cases to test how accurately it could diagnose CIN lesions and cervical cancer.
The study found that the AI-based model was able to identify cervical precancerous lesions with high accuracy. In identifying lesions, the model had:
-
A sensitivity of 85% for CIN3 lesions, 86% for CIN2 lesions, and 87% for CIN1 lesions. Sensitivity is the percentage of people with a lesion who were correctly identified by the model as having a lesion.
-
A specificity of 73% for CIN3 lesions, 67% for CIN2 lesions, and 70% for CIN1 lesions. Specificity is the percentage of people who did not have a lesion and were correctly identified by the model as not having a lesion.
-
An area under the curve of 89% for the lesion area for CIN3 lesions and of 81% for both CIN2 and CIN1 lesions. The area under the curve indicates the overall accuracy of the model.
-
An accuracy of 95% for the number of lesions identified among CIN3 lesions, 93% for CIN2 lesions, and 97% for CIN1 lesions.
The model was also able to display a heatmap of the affected area with the highest acetic acid intensity, indicating where it was most likely for abnormal cells to be found, that corresponded with the actual biopsy location.
What does this mean for patients: For people who require a colposcopy after receiving abnormal Pap test results, an AI-based model may be helpful in accurately identifying cervical precancerous lesions, thus improving early detection and likelihood of curative therapy. This model could be especially useful in places where there may be fewer doctors trained in reading colposcopy results.
“Currently, there is no certification system for performing colposcopies in Japan, and the quality and interpretation of these examinations varies. Our study aimed to develop an artificial intelligence (AI)-based tool that reproduced colposcopy examination techniques of specialists to be used as a diagnostic aid by accurately identifying CIN lesions and guiding tissue sampling locations.”
— lead study author Akihiko Ueda, MD
Kyoto University
Kyoto, Japan
Return to top
Liquid biopsy may help find common cancers before symptoms develop
Who does this study affect: People who have a moderate to high risk of cancer but no symptoms.
What did this study find: Results from the K-DETEK clinical trial in Vietnam have shown that a type of liquid biopsy called SPOT-MAS (Screening for the Presence Of Tumor by Methylation And Size) may be useful for detecting certain common cancers in people with no symptoms. The SPOT-MAS only looks for the 5 most common cancers in Vietnam: liver, breast, colorectal, stomach, and lung cancer. It is a type of liquid biopsy called a multiple cancer early detection test or MCED.
The researchers in this study wanted to see if the SPOT-MAS test could be used to successfully find early cases of cancer among Vietnamese people. This study includes 10,000 people aged 40 years or older with no symptoms of cancer but moderate to high risk of developing cancer. It was conducted in 13 large hospitals and 1 research institute in Vietnam. The participants were observed at 6 and 12 months. When the researchers analyzed the data, they had completed analyses for 2,795 study participants. They found that the SPOT-MAS correctly detected cancer in 60% of cases, meaning that for every 100 positive tests, 60 of them will actually have cancer. In addition, the test was able to correctly identify the tumor’s location in 83.3% of cases. If SPOT-MAS detected cancer, then a patient received additional testing by doctors to confirm whether they really had cancer and then guide treatment decisions.
cancer screening tools, such as mammography and colonoscopy, usually only test for a single type of cancer and require separate appointments and procedures. In some parts of the world, this makes cancer screening difficult. Giving a single Blood test to screen people for several common types of cancer may be a convenient way to find cancer in people before they develop symptoms.
What does this mean for patients? The SPOT-MAS may be a helpful tool for initially screening people for common types of cancer, particularly in lower- and middle-income countries.
“Common screening methods are often invasive, inaccessible, and involve separate procedures to screen individual cancer types. Affordable, accessible, noninvasive multicancer screening tests are needed for early detection, especially in a lower-middle income country like Vietnam. Our study provides clinical evidence for the applicability of the SPOT-MAS circulating tumor DNA-based assay as a complementary method in early cancer detection.”
—senior study author Le Son Tran, PhD
Medical Genetics Institute
Ho Chi Minh City, Vietnam
Return to top
Like what you’ve read here at cancer.Net? Sign up for our monthly Inside cancer.Net e-newsletter and follow cancer.Net on Facebook and Twitter for news about the latest in cancer care and treatment.
[ad_2]
cancer.net/blog/2023-07/2023-asco-breakthrough”>Source link
17th Edition of Oncology Award | 16-18 October 2023 | Paris, France
International Research Awards on Oncology and Cancer Research. It sounds like a prestigious award aimed at feting and recognizing the benefactions and achievements of experimenters and exploration associations in the field of oncology and cancer exploration. The eligibility criteria for the award is open to experimenters and scholars of all ethnicities, which is great for promoting diversity in the field. The appointees are estimated grounded on their once accomplishments, exploration excellence, and academic achievements, which is a good index of their impact in the field. Overall, the award appears to be an excellent way to admit and celebrate the achievements of experimenters working in the field of oncology and cancer exploration.
Theme: To celebrate researcher achievements and motivate them to continue on their path
More information – https://oncologyandcancerresearch.blogspot.com/
International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco
For Inquiries: oncology@pencis.com
#shorts #shortsvideo #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference #CardioOnc #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney
CONNECT HERE:-
Facebook : https://www.facebook.com/Conference-101261931798599
twitter :https://twitter.com/Samirabellil
pinterest : https://in.pinterest.com/OncologyandCancerResearch/
Blog :https://oncologyandcancerresearch.blogspot.com/
tumblr :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin : https://www.linkedin.com/in/cathenna-malia-a20834219/
source
17th Edition of Oncology Summit | 16-18 October 2023 | Paris, France
The International Conference on Oncology and Cancer Research is an event that brings together researchers, healthcare professionals, and experts from the field of oncology and cancer research to discuss the latest developments and advancements in the field. The conference provides a platform for sharing new ideas, scientific knowledge, and research findings among the participants. The conference usually includes keynote speeches, plenary sessions, oral presentations, poster sessions, and workshops. The conference topics may include but are not limited to, the following areas of cancer research: Basic cancer research, Clinical trials and studies, Cancer prevention and early detection, Cancer diagnosis and treatment, Cancer therapies and new treatments, Cancer epidemiology and statistics, Cancer informatics and technology, Cancer rehabilitation and palliative care, Cancer policy and advocacy. The International Conference on Oncology and Cancer Research is an opportunity for professionals from various backgrounds to come together and collaborate on ways to improve the diagnosis, treatment, and overall management of cancer.
More information – https://oncologyandcancerresearch.blogspot.com/
International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco
For Inquiries: oncology@pencis.com
#shorts #shortsvideo #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference #CardioOnc #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney
CONNECT HERE:-
Facebook : https://www.facebook.com/Conference-101261931798599
twitter :https://twitter.com/Samirabellil
pinterest : https://in.pinterest.com/OncologyandCancerResearch/
Blog :https://oncologyandcancerresearch.blogspot.com/
tumblr :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin : https://www.linkedin.com/in/cathenna-malia-a20834219/
source